rpt193
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 12, 2019 (NCT04271514)
Timeline
Indications
Mechanism of action
- C-C chemokine receptor type 4ANTAGONIST
CCR4 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05935332 | Phase 2 | Jul 5, 2023 | RAPT Therepeutics, Inc. |
| NCT06087978 | Phase 1 | Jul 5, 2023 | RAPT Therepeutics, Inc. |
| NCT05399368 | Phase 2 | Jun 7, 2022 | RAPT Therepeutics, Inc. |
| NCT04271514 | Phase 1 | Aug 12, 2019 | RAPT Therepeutics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| RAPT Therepeutics, Inc. | For profit | 4 | 4 | 2 | 2019 |
1 organizations
Page 1 / 1